If the GLP-1 neurons in the hindbrain are activated by physiological or pharmacological methods, or if the central GLP-1 receptors are activated, Rinaman said, this suppresses motivated behaviors such as food intake, drug self-administration, operant responding for drugs, and exploratory behaviors (Maniscalco and Rinaman, 2018)
Supportive secondary endpoints were not included in the statistical testing hierarchy and were: achievement of weight loss of 20% at week 104
dose reduction of these medications may be needed) [1] Acute kidney injury risk, particularly with severe gastrointestinal adverse reactions causing dehydration Diabetic retinopathy complications , particularly in patients with a history of retinopathy who experience rapid improvement in blood glucose [1] Acute gallbladder disease including cholelithiasis and cholecystitis The FDA label includes a boxed warning about thyroid C-cell tumors observed in rodent studies, though the relevance to humans remains uncertain
Never discontinue prescribed medicine without medical guidance, particularly if you have diabetes, as this could affect glycaemic control
Our team supports you in making lasting changes that complement the medications appetite-suppressing effects